CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials

Rekowski, J. orcid.org/0000-0002-5207-3864, Guo, C., Solovyeva, O. et al. (35 more authors) (2025) CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials. eClinicalMedicine, 79. 102987. ISSN 2589-5370

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 The Authors. Except as otherwise noted, this author-accepted version of a journal article published in eClinicalMedicine is made available via the University of Sheffield Research Publications and Copyright Policy under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/

© 2024 The Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial Licence (https://creativecommons.org/licenses/by-nc/4.0/)

Keywords: Early phase trials; Phase I; Dose-finding; Dose escalation/de-escalation; Reporting guidance; CONSORT-DEFINE; CONSORT
Dates:
  • Published: January 2025
  • Published (online): 10 January 2025
  • Accepted: 20 November 2024
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 20 Jan 2025 11:55
Last Modified: 03 Feb 2025 12:31
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: 10.1016/j.eclinm.2024.102987
Open Archives Initiative ID (OAI ID):

Export

Statistics